Tumor Targeting in Cancer Therapy Book

	Preface
	Contributors
1	The Current Status of Tumor Targeting: A Review	3
2	Clinical Applications of Targeted Therapeutics	79
3	Targeting the CD22 Receptor with RNA Damaging Agents	109
4	The Development of Liposomes for Enhanced Delivery of Chemotherapeutics to Tumors	119
5	Overcoming Multiple Drug Resistance with Anti-Pgp Carrier	137
6	Targeting with Transferrin	151
7	Synthesis and Evaluation of Paclitaxel Immunoconjugate with Antitumor Activity In Vitro	165
8	The Use of Drug-Monoclonal Antibody Conjugates for the Treatment of Cancer	179
9	Targeting Vascular Endothelium with Antibodies	199
10	Targeting B-Cell Non-Hodgkin's Lymphoma with Monoclonal Antibodies	211
11	From Bench to Bedside: Development of Rituximab (Rituxan), A Monoclonal Antibody for the Therapy of Non-Hodgkin's Lymphoma	225
12	Mylotarg: The First Antibody-Targeted Chemotherapy Agent	239
13	[superscript 188]Rhenium-Labeled Trisuccin-[Delta]Ch2HuCC49 as a Radioimmunotherapy Model in Nude Mice	257
14	General Approach for Targeting Toxins	279
15	Antibody-Toxin Conjugates: Chemistry of Coupling and Purification	289
16	Shiga-Like Toxins as Targeted Anticancer Agents	307
17	Antibody-Directed Enzyme Prodrug Therapy with Carboxypeptidase G2: Clinical Studies	321
18	Photodynamic Therapy: Targeting Cancer Cells with Photosensitizer-Bioconjugates	329
19	Tumor Targeting Using PEG-m-THPC for Photodynamic Therapy in a Rat Ovarian-Cancer Model	363
20	Targeting Tumors with Magnetic Drugs	379
21	Internalization of Antibodies	391
22	Bioconjugation and Biodistribution	411
23	Principles of Antitumor Targeting of Cytotoxic Drugs	431
24	Targeting by Antibody or Ligand: Which Is Better?	449
	Index	459